Nilsine Partners LLC Acquires 4,023 Shares of McKesson Corporation $MCK

Nilsine Partners LLC lifted its holdings in McKesson Corporation (NYSE:MCK) by 84.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,768 shares of the company’s stock after buying an additional 4,023 shares during the quarter. Nilsine Partners LLC’s holdings in McKesson were worth $6,625,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. University of Texas Texas AM Investment Management Co. bought a new position in shares of McKesson in the fourth quarter worth about $25,000. Swiss RE Ltd. acquired a new position in shares of McKesson during the fourth quarter worth approximately $26,000. Delos Wealth Advisors LLC bought a new stake in shares of McKesson during the second quarter valued at approximately $27,000. State of Wyoming bought a new stake in shares of McKesson during the second quarter valued at approximately $29,000. Finally, Kingdom Financial Group LLC. bought a new stake in shares of McKesson during the fourth quarter valued at approximately $33,000. Institutional investors own 85.07% of the company’s stock.

Insiders Place Their Bets

In other McKesson news, Director Bradley E. Lerman sold 301 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $892.33, for a total value of $268,591.33. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Brian S. Tyler sold 8,463 shares of the business’s stock in a transaction dated Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total value of $6,715,898.28. Following the transaction, the chief executive officer owned 5,919 shares of the company’s stock, valued at $4,697,081.64. The trade was a 58.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 22,156 shares of company stock valued at $17,305,242. 0.06% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts recently weighed in on MCK shares. Citigroup boosted their price objective on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Friday, July 24th. Royal Bank Of Canada started coverage on McKesson in a research report on Wednesday, August 19th. They issued a “sector perform” rating and a $845.00 price objective on the stock. Wells Fargo & Company lifted their target price on McKesson from $812.00 to $933.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 11th. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Finally, Barclays upped their price target on McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $973.44.

McKesson Price Performance

MCK opened at $907.35 on Friday. The company has a market cap of $105.79 billion, a price-to-earnings ratio of 24.28, a price-to-earnings-growth ratio of 1.81 and a beta of 0.30. The firm has a 50 day simple moving average of $848.13 and a 200 day simple moving average of $843.09. McKesson Corporation has a fifty-two week low of $682.35 and a fifty-two week high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, beating the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The business had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. During the same period in the prior year, the business posted $8.26 earnings per share. McKesson’s revenue was up 7.7% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, analysts expect that McKesson Corporation will post 44.65 EPS for the current year.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be given a $0.94 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. This is an increase from McKesson’s previous quarterly dividend of $0.82. McKesson’s dividend payout ratio is 10.06%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.